PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.

Lanfranco PellesiBasit Ali ChaudhryAnne Luise Haulund VollesenAgneta Henriette SnoerKatrine BaumannPer Stahl SkovRigmor Højland JensenMessoud Ashina

Published in: Cephalalgia : an international journal of headache (2021)

Cluster headache attacks provoked by either PACAP38 or vasoactive intestinal polypeptide were not accompanied by alterations of plasma calcitonin gene-related peptide, tryptase or histamine. The provoked attacks may not be mediated by calcitonin gene-related peptide or mast cell activation.Trial Registration: The study is registered at ClinicalTrials.gov (NCT03814226).

Keyphrases

genome wide
copy number
clinical trial
drug induced
study protocol
randomized controlled trial
genome wide identification
high glucose
phase iii
genome wide analysis